로딩 중…
지수 로딩 중…
UroGen Pharma Ltd.
URGN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$33.57+2.32%
2026-06-18
Price Chart
UroGen Pharma Ltd.+125.76%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.64B |
| Revenue | $140M |
| Net Income | $-133M |
| Total Assets | $254M |
| Net Assets | $26M |
| Value | |
| P/B | 64.10x |
| P/S | 11.64x |
| FCF Yield | -10.15% |
| Profitability | |
| ROA | -52.51% |
| Op. Margin | -77.02% |
| Revenue Growth | 151.60% |
| Financial Health | |
| Debt Ratio | 1481.26% |
| Total Debt | $197M |
| FCF | $-166M |
| Cash | $111M |
| Current Ratio | 4.69x |
| Performance | |
| 1Y Return | 125.76% |
| 1M Return | 18.79% |
| From 52W High | -0.65% |
| 1Y MDD | -42.22% |
| Trading | |
| Volume | 810,928 shares |
| Trading Value | $27M |
| Per Share | |
| EPS | $-3.12 |